From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery.

Cuffari B

Open source

DOI: 10.2196/101366
Published: 2026 May 29
Container: Journal of medical Internet research
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2196/101366,
  title = {From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery.},
  author = {Cuffari B},
  year = {2026},
  journal = {Journal of medical Internet research},
  doi = {10.2196/101366},
  url = {https://doi.org/10.2196/101366}
}

RIS

TY  - JOUR
TI  - From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery.
AU  - Cuffari B
PY  - 2026
JO  - Journal of medical Internet research
DO  - 10.2196/101366
UR  - https://doi.org/10.2196/101366
ER  -

APA

B, C. (2026). From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery.. Journal of medical Internet research. https://doi.org/10.2196/101366

Source records

pubmed · retrieved 2026-09-25T23:35:15.393Z
europe-pmc · retrieved 2026-09-25T23:35:15.399Z
doaj · retrieved 2026-09-25T23:35:15.406Z